GCK and cardiovascular disorder: Indeed, genetic evidence suggests that the impaired interaction of the GCK- GCKR complex may increase the risk of liver and cardiovascular diseases; therefore, the development of future GCK activators should avoid interfering with the GCK- GCKR interaction and should instead activate liver-specific GCK [39,40].